Suppression of Cytotoxicity of Diphtheria Toxin by Monoclonal Antibodies Against Phosphatidylinositol Phosphate  by Friedman, Richard L. et al.
SUPPRESSION OF CYTOTOXICITY OF DIPHTHERIA
TOXIN BY MONOCLONAL ANTIBODIES AGAINST
PHOSPHATIDYLINOSITOL PHOSPHATE
RICHARD L. FRIEDMAN AND BARBARA H. IGLEWSKI
Department ofMicrobiology and Immunology, University ofOregon Health Sciences Center, Portland,
Oregon 97201 U.S.A.
FRITZ ROERDINK AND CARL R. ALVING
Department ofMembrane Biochemistry, Walter Reed Army Institute ofResearch, Washington, D. C.
20012 U.S.A.
The structure and chemical class of the cellular receptor
for diphtheria toxin (DT) has not yet been determined.
The receptor has been proposed to be a protein (1), a
carbohydrate (2), or a glycoprotein (3). Recently it has
been demonstrated that DT is a phosphate-binding protein
(4-6). We have shown that DT binds specifically to the
phosphate portion of some, but not all, phospholipids in
liposomes (4). Based on these findings we proposed that
the receptor for DT includes a minor membrane phosphol-
ipid such as phosphatidylinositol phosphate (PIP). To test
this hypothesis we have examined the ability of mono-
clonal antibodies directed against liposomal phospholipids
to inhibit cytotoxicity of DT.
RESULTS AND DISCUSSION
Hybridoma monoclonal "anti-liposome" antibodies were
produced after injecting a mouse with liposomes contain-
ing dimyristoyl phosphatidylcholine (DMPC), cholesterol,
lipid A, and PIP (7). The specificity of a typical mono-
clonal anti-PIP antibody is shown in Table I. Immune
damage to test liposomes was inhibited by inositol hexa-
phosphate, phosphocholine, and nucleotides (ATP >
AMP), but not by choline or inositol. The specificity of the
anti-PIP antibody apparently was similar to that of DT in
that both proteins had the ability to bind both phosphate
and PIP, and both were inhibited by nucleotides (ATP >
AMP) (4, 9). We reasoned that if PIP were the cellular
receptor for DT, or even if the phosphate (i.e., PIP)
binding site of DT were important only in the internaliza-
tion of DT, then the toxicity of DT might be blocked by a
monoclonal anti-PIP antibody. Such blocking did occur, as
shown below.
The cytotoxicity assay consisted of incubating 0.01 ml
of undiluted ascites fluid containing or lacking anti-PIP
monoclonal antibody for 30 min at 370C with 2 x 104
Chinese hamster ovary (CHO) cells previously attached
(overnight) to microtiter wells. Various concentrations of
DT were then added to the cells and the incubation was
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continued for an additional 30 min. The cells were washed
to remove unbound toxin, fresh media were added, and
toxicities were monitored microscopically for four days.
The minimum cytotoxic dose (MCD) of toxin is defined as
that amount required to kill 100% of the CHO cells.
Preincubation of the CHO cells with control ascites fluid
lacking anti-PIP antibody did not alter the MCD of DT
(Table II). Preincubation with each of four different
anti-PIP monoclonal antibodies increased the MCD for
DT from 600 ng to at least 10,000 ng (Table II). Each of
the anti-PIP monoclonal antibodies protected CHO cells
from subsequent DT toxicity, provided the antibody was
preincubated with CHO cells. Suppression of cytotoxicity
was not observed when anti-PIP antibodies and DT were
mixed and added simultaneously to CHO cells (data not
shown). These data indicate that the monoclonal anti-PIP
antibody inhibits DT cytotoxicity by interacting with the
CHO cell rather than with the toxin molecule.
Pseudomonas toxin A, has an intracellular mechanism
TABLE I
SPECIFICITY OF ANTI-PIP ANTIBODIES
Percent of
trapped glucose released*
Inhibitor at inhibitor concentration of
8 mM 30 mM
None 46 46
Inositol 45 47
Inositol hexaphosphate 0 1
Choline 48 42
Phosphocholine 3
AMP 40 27
ATP 22 12
*Complement-dependent immune damage resulting in release of trapped
glucose from liposomes was assayed as previously described (8) The
liposomes consisted of DMPC, cholesterol, dicetyl phosphate, and PIP in
molar ratios of 1/0.75/0.1 1/0.1. Each 0.005 ml aliquot of liposomes was
incubated with 10' ml of ascites fluid containing anti-PIP antibodies
and with 0.08 ml of guinea pig complement.
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TABLE II
ABILITY OF ANTI-PIP MONOCLONAL ANTIBODIES TO
INHIBIT CHO CELL CYTOTOXITY INDUCED BY
BACTERIAL TOXINS
MCD
Antibody* Pseudomonas
DT toxin A
(ng/2 x 104 cells)
None (control) 600 200
anti-PIP- I >10,000 200
anti-PIP-2 10,000 200
anti-PIP-3 10,000 200
anti-PIP-4 10,000 200
*Each anti-PIP antibody consisted of ascites fluid derived from a
separate clone after a single immunization and fusion. The original
immunized mouse was BALB/c, and spleen cells were fused with
myeloma line P3-X63-Ag8 (10). The control consisted of ascites fluid
derived from fusion of cells from an unimmunized mouse
of action identical to that of DT, but the two toxins utilize
different cell surface receptors ( 11). Indeed, Table II
shows that the anti-PIP antibodies did not influence the
toxicity of Pseudomonas toxin A.
Our data are compatible with our previous suggestion
(4) that the cellular receptor for DT is a membrane
phospholipid, and that PIP is a promising candidate as the
receptor molecule. Even if PIP is not the initial receptor, it
may have an important role during internalization of the
toxin, or during channel formation through the lipid
bilayer (12).
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